Biopharma Revenue Forecasting That Drives Decision Making and Investments Course

Biopharma Revenue Forecasting That Drives Decision Making and Investments Course is organized by Biotech Primer, Inc and will be held from Nov 17 - 18, 2021.

Who should attend:
Appropriate for those who need a foundational understanding of revenue forecasting and how it pertains to drug pricing. Ideal for anyone who works in finance, marketing, business development, project management and research development.

Description:
This is a two-day tactical course invaluable for organizations that work in both preclinical/early clinical development all the way to mature biopharma. Develop knowledge of the core elements of revenue forecasting including pricing, competitive assessments, and epidemiology. Understand how the geography of the US, EU, Japan, China and the rest of the world impacts revenue forecasting. Join our industry experts as they bring to life the ‘logical process’ of revenue forecasting using real-life case studies that participants work through together.
The scope of this course includes:
• Geography: US, EU5, Japan, China, ROW
• Therapeutic area: oncology, specialty, rare diseases, gene therapy

Takeaways:
• Develop a broad understanding of how and why revenue forecasts are developed to drive strategic decision making and investing in the biopharma industry.
• Develop a broad understanding of how and why revenue forecasts are developed to drive strategic decision making and investing in the biopharma industry.
• Become fluent in the core elements of revenue forecasting including: epidemiology, competitive assessments, market share assignment, duration of therapy, pricing, gross-to-net margins, and annual price increases.
• Understand how revenue forecasting varies across geographies and the considerations that need to be accounted.
• Demonstrate the logical process (workstreams) that leads to effective, defensible revenue forecasting and the interpretation of its findings.
• Generate insights and actionable decisions from the forecasting process. 

Additional details will be posted as soon as information is available.